Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

NRX Pharmaceuticals, Inc.

NASDAQ: NRXP · Life Sciences · 6 alerts · CIK 1719406

Share price
$2.15Close, Nov 16
Market cap
$93.1M
Shares outstanding
43.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All NRX Pharmaceuticals, Inc. filings on SEC EDGAR ↗

6:02 AM ET 8-K
Business Update

NRX Pharmaceuticals Business Update

NRx Pharmaceuticals received notification from the FDA reclassifying a previously 'Major' amendment to its Abbreviated New Drug Application (ANDA) for preservative-free ketamine as a 'Minor' amendment. This reclassification accelerates the regulatory timeline, resulting in a revised GDUFA goal date of November 10, 2026.

Counterparty
FDA Office of Generic Drugs

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.